A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia

BACKGROUND: Hyperkalemia is associated with many chronic diseases and renin-angiotensin-aldosterone system inhibitor therapy. Sodium zirconium cyclosilicate (SZC), an oral, highly selective cation-exchanger, is approved for the treatment of hyperkalemia. METHODS: This phase 3, multicenter, open-labe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Exp Nephrol
Main Authors: Kashihara, Naoki, Yamasaki, Yoshimitsu, Osonoi, Takeshi, Harada, Hiromasa, Shibagaki, Yugo, Zhao, June, Kim, Hyosung, Yajima, Toshitaka, Sarai, Nobuaki
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7880936/
https://ncbi.nlm.nih.gov/pubmed/33098526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-020-01972-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados